CVS · CIK 0000064803 · FY2025 live · 2025-12-31
CVS HEALTH Corp
View as
Model
Z″
FY2025
0.99
Zone
Distress
vs FY2024
−0.08
Market DD
—
1y PD
—
0.99
Classic Z 2.17
Z″ 0.99 · distress below 1.10, grey to 2.60, safe above.
Z″ factor contributions
X1 Working capital / assets
Short-term liquidity. Carries more weight in Z″ than in classic Z.
−0.066.56 × = −0.36X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
0.243.26 × = 0.79X3 EBIT / assets
Operating return on assets. Highest weight in Z″.
0.026.72 × = 0.12X4 Book equity / liabilities
Book equity versus the liability stack. Sales / assets is omitted so asset-light names keep turnover from dragging the score.
0.421.05 × = 0.44
Five-year path
Z″ plus liquidity (working capital / assets) and earnings (EBIT / assets) over the last 5 annual filings.
Meridian Rank
51.33
from 50.53
0–100 · Z″ family
Book standing
47
Year change
46
Market PD
—
O-score
70
Events on this name
Same published rows as Today.
Weaker in 4 consecutive annual prints (FY2022–FY2025)
high · 78
- Consecutive weaker prints: — → 4
- From FY: — → 2022
- Through FY: — → 2025
- Live score: 1.07 → 0.99
Overview
rule-v1
CVS HEALTH Corp is on Z″ at 0.99 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print; book equity / liabilities is the runner-up. Versus FY2024 the live print is still distress (−0.08 from 1.07). No market tape loaded. Z″ omits sales/assets so asset-light names keep turnover from dragging the score. X4 is book equity on every name.
Book screen Distress; market PD —. Market PD has not been priced on this name.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Z″ scores · 47th percentile in Consumer.
Filing line items
Current assets
$74.7B
Total assets
$253.5B
Current liabilities
$88.7B
Total liabilities
$178.2B
Working capital
−$14.0B
Retained earnings
$61.2B
EBIT
$4.7B
Total sales
$402.1B
Book equity
$75.2B
Accession 0000064803-26-000010. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Z″ is the live score. View as is a display overlay. X4 is book equity. Pulled 14 Sept 2026.